Sarissa Capital Acquisition Corp.
SRSAW
NASDAQ Capital Market0.00
USD
- -
- -
Sarissa Capital Acquisition Corp.
SRSAW
(NASDAQ Capital Market)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Sarissa Capital Acquisition Corp. is a special purpose acquisition company (SPAC) incorporated in 2020 and headquartered in Greenwich, Connecticut. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, primarily targeting the healthcare and biopharmaceutical industry in the United States and other developed countries. Sarissa Capital Acquisition Corp. does not have significant standalone operations but aims to identify and acquire a business within its specified industry focus. The company completed an initial public offering (IPO) in October 2020, raising approximately $175 million with units consisting of one Class A ordinary share and one-third of one redeemable warrant. A major recent change is that Sarissa Capital Acquisition Corp. announced in 2022 that it would not consummate a business combination and instead opted to liquidate its trust as of October 31, 2022, returning funds to shareholders and effectively winding down its SPAC activities. The firm was sponsored by investment funds managed by Sarissa Capital Management LP, founded by Dr. Alexander John Denner.